SlideShare a Scribd company logo
Sub-acute oral toxicity study
Prepared by, Arghya Chowdhury
Roll No.:18162027
M.Pharm 2nd Semester
Department of Pharmaceutical Engineering and Technology
IIT(BHU), Varanasi
Ethynyl estradiol
• ANDA : 207081 on 05/17/2017 from AUROBINDO PHARMA LTD
• CAS No. : 57-63-6
• An agonist of the estrogen receptors.
• Used as contraception in combined oral contraceptives (COC)
• Bioavailability : 38–48%
• Protein binding : 97–98% (to albumin)
• Elimination half-life : 7–36 hours
• Excretion : Feces: 62% and Urine: 38%
2
Evaluate the safety of ethynyl estradiol
• The experimental protocol was approved by the IAEC (Institutional Animal
Ethical Committee).
• Care of the experimental animals taken according to the CPCSEA
guidelines.
• Sub-acute toxicity study was carried out in rats by using OECD 407
guidelines.
3
Repeated Dose 28-Day Oral Toxicity Study
• The test substance is orally administered daily in graduated doses to several groups, one dose
level per group for a period of 28 days.
• During this period the animals are observed closely, each day for signs of toxicity.
• Endpoints : clinical observations, blood analysis, whole body gross necropsy, and micros-
copic examination of all organs and tissues (histopathology).
• Significance : the characterization of the test substance toxicity, for an indication of the
dose response relationship and the determination of the No-Observed Adverse Effect Level
(NOAEL).
4
Animal handling and care
• Temperature : 22°C (± 3°C).
• Relative humidity : at least 55±5% with 12-h light/dark cycle (0600–1800
hours).
• Animals: SD rats aged 6 weeks(130 gms-200 gms) of both sexes.
• Access to food and water were maintained under standard laboratory
conditions.
• Housed individually in stainless steel, wire-mesh cages during the study.
5
Study design
• Grouping : Both sexes of rats (130-200g) were divided into four groups with 10 animals (5
males plus 5 females in each).
• Dosing :
 Group I (control)-olive oil solution (5 ml/kg)
 Group II – 10 μg/kg EE
 Group III – 50 μg/kg EE
 Group IV – 200 μg/kg EE
• Dosing frequency : Daily from 7 weeks of age for at least 28 days.
6
Parameters
• Euthanasia : exsanguination under ether anesthesia.
• Blood samples collection : from the abdominal aorta.
• Parameters considered :
General observations
Body weight and food consumption
Hematology, Histopathological findings
Spermatology, Estrous cycling
7
General observations
8
• Autonomic activity (e.g. lacrimation, pupil size, respiratory pattern),
• Changes in gait, posture,
• Presence of clonic or tonic movements.
• Sensory reactivity to stimuli of different types (e.g. auditory, visual),
• Assessment of grip strength,
• Motor activity assessment.
Body weight and food consumption
9
• Individual body weight was recorded ;
twice weekly
immediately before necropsy.
• Food consumption was measured weekly.
Hematology, Histopathological findings
10
• Hematology examination : RBC count, WBC count, hemoglobin concentration,
hematocrit value , platelet count, reticulocyte count, prothrombin time and
differentiation of leukocytes.
• Histopathological examination : organs were fixed in 10% neutral buffered
formalin and examined: prostates(ventral prostate and dorsolateral prostate),
seminal vesicles, ovaries, uterus, vagina, mammary gland, brain, thyroids, adrenals,
liver, spleen, kidneys, heart, lungs, pancreas, thymus, parathyroids and pituitary
glands.
• The epididymes and testes were fixed in Bouin’s solution and examined.
Spermatology, Estrous cycling
• Spermatology :
Sperm motility (100 spermatozoa in Ham’s F10 tissue culture
medium at 37°C).
Viability (decrease in motility during 5 min).
• Estrous cycling : determined daily by vaginal smears stained with Gimsa
from day 15 to the day 21.
1111
Results
• General observations : no abnormalities in rats given EE.
• Food consumption was reduced in both males and females ; body weight gain
significantly depressed only in the males of the 200 µg/kg group.
• RBC counts decreased in females of 50 and 200 µg/kg groups ; haemoglobin
concentration and haematocrit values decreased in males of 200 µg/kg group.
• Abnormal estrous cycling was observed in female rats of the 50 and 200 µg/kg groups.
• Adrenal cortical hyperplasia was detected in males ; Splenic hemosiderosis were
detected in females of 200 µg/kg group.
12
Analysis
• Data obtained was analyzed by using one way ANOVA followed by
Dunnett’s test and p<0.05 was considered as statistically significant.
• Ethynyl estradiol taken orally exerts following toxic effects;
Anemia,
Breast tenderness,
Atrophy of the prostates,
Weight change.
1313
References
• Arch Toxicol (2002) 76: 65–74
• McLachlan JA, Korach KS (1995) Estrogens in the environment: global
health implications. Environ Health Perspect 103: 3–4
14
Thank You

More Related Content

What's hot

Schedule y for toxicity studies
Schedule y  for toxicity studiesSchedule y  for toxicity studies
Schedule y for toxicity studiesKrushangiShah233
 
Invivo Carcinogenecity Studies
Invivo Carcinogenecity StudiesInvivo Carcinogenecity Studies
industrial prespectives of IND
industrial prespectives of INDindustrial prespectives of IND
industrial prespectives of IND
Ravi Kumar katukuri
 
IND Enabling Studies by Kashikant Yadav
IND Enabling Studies by Kashikant YadavIND Enabling Studies by Kashikant Yadav
IND Enabling Studies by Kashikant Yadav
Kashikant Yadav
 
IND Enabling Studies (IND)
IND Enabling Studies  (IND)IND Enabling Studies  (IND)
IND Enabling Studies (IND)
Anurag Chourasia
 
Safety Pharmacology
Safety PharmacologySafety Pharmacology
Safety Pharmacology
Pavana K A
 
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
helasri gummadi
 
Safety pharmacology tier 2
Safety pharmacology  tier 2Safety pharmacology  tier 2
Safety pharmacology tier 2
ragini Dani
 
test item characterization of regulatory of toxicological studies
test item characterization of regulatory of toxicological studies test item characterization of regulatory of toxicological studies
test item characterization of regulatory of toxicological studies
SonaliJain736101
 
Screening models for acute eye irritation &amp; skin sentization
Screening models for acute eye irritation &amp; skin sentizationScreening models for acute eye irritation &amp; skin sentization
Screening models for acute eye irritation &amp; skin sentization
pradnya Jagtap
 
Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3
Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3
Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3
SONALPANDE5
 
toxicokinetics and saturation kinetics
toxicokinetics and saturation kineticstoxicokinetics and saturation kinetics
toxicokinetics and saturation kinetics
pharmacistnitish
 
PPT On Female Reproductive Toxicology
PPT On Female Reproductive Toxicology PPT On Female Reproductive Toxicology
PPT On Female Reproductive Toxicology
Naveen K L
 
Skin sensitisation (OECD: 406).
Skin sensitisation (OECD: 406).Skin sensitisation (OECD: 406).
Skin sensitisation (OECD: 406).
Dr Ajay Mandal
 
Acute dermal toxicity studies
Acute dermal toxicity studies Acute dermal toxicity studies
Acute dermal toxicity studies
jeshicabulsara
 
List of studies needed for IND submission
List of studies needed for IND submissionList of studies needed for IND submission
List of studies needed for IND submission
Shivanshu Bajaj
 
Regulatory guidelines for conducting toxicity studies
Regulatory guidelines for conducting toxicity studiesRegulatory guidelines for conducting toxicity studies
Regulatory guidelines for conducting toxicity studies
HimikaRathi
 
Acute dermal toxicity-402
Acute dermal toxicity-402Acute dermal toxicity-402
Acute dermal toxicity-402
Dr Ajay Mandal
 
Reproductive toxicology studies ACCORDING TO OECD guidlines 422
Reproductive toxicology  studies ACCORDING TO OECD guidlines 422 Reproductive toxicology  studies ACCORDING TO OECD guidlines 422
Reproductive toxicology studies ACCORDING TO OECD guidlines 422
SONALPANDE5
 
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptxTOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
Anmolkanda06
 

What's hot (20)

Schedule y for toxicity studies
Schedule y  for toxicity studiesSchedule y  for toxicity studies
Schedule y for toxicity studies
 
Invivo Carcinogenecity Studies
Invivo Carcinogenecity StudiesInvivo Carcinogenecity Studies
Invivo Carcinogenecity Studies
 
industrial prespectives of IND
industrial prespectives of INDindustrial prespectives of IND
industrial prespectives of IND
 
IND Enabling Studies by Kashikant Yadav
IND Enabling Studies by Kashikant YadavIND Enabling Studies by Kashikant Yadav
IND Enabling Studies by Kashikant Yadav
 
IND Enabling Studies (IND)
IND Enabling Studies  (IND)IND Enabling Studies  (IND)
IND Enabling Studies (IND)
 
Safety Pharmacology
Safety PharmacologySafety Pharmacology
Safety Pharmacology
 
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
 
Safety pharmacology tier 2
Safety pharmacology  tier 2Safety pharmacology  tier 2
Safety pharmacology tier 2
 
test item characterization of regulatory of toxicological studies
test item characterization of regulatory of toxicological studies test item characterization of regulatory of toxicological studies
test item characterization of regulatory of toxicological studies
 
Screening models for acute eye irritation &amp; skin sentization
Screening models for acute eye irritation &amp; skin sentizationScreening models for acute eye irritation &amp; skin sentization
Screening models for acute eye irritation &amp; skin sentization
 
Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3
Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3
Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3
 
toxicokinetics and saturation kinetics
toxicokinetics and saturation kineticstoxicokinetics and saturation kinetics
toxicokinetics and saturation kinetics
 
PPT On Female Reproductive Toxicology
PPT On Female Reproductive Toxicology PPT On Female Reproductive Toxicology
PPT On Female Reproductive Toxicology
 
Skin sensitisation (OECD: 406).
Skin sensitisation (OECD: 406).Skin sensitisation (OECD: 406).
Skin sensitisation (OECD: 406).
 
Acute dermal toxicity studies
Acute dermal toxicity studies Acute dermal toxicity studies
Acute dermal toxicity studies
 
List of studies needed for IND submission
List of studies needed for IND submissionList of studies needed for IND submission
List of studies needed for IND submission
 
Regulatory guidelines for conducting toxicity studies
Regulatory guidelines for conducting toxicity studiesRegulatory guidelines for conducting toxicity studies
Regulatory guidelines for conducting toxicity studies
 
Acute dermal toxicity-402
Acute dermal toxicity-402Acute dermal toxicity-402
Acute dermal toxicity-402
 
Reproductive toxicology studies ACCORDING TO OECD guidlines 422
Reproductive toxicology  studies ACCORDING TO OECD guidlines 422 Reproductive toxicology  studies ACCORDING TO OECD guidlines 422
Reproductive toxicology studies ACCORDING TO OECD guidlines 422
 
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptxTOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
 

Similar to SUB ACUTE ORAL TOXICITY

Reproductive toxicity studies
Reproductive toxicity studiesReproductive toxicity studies
Reproductive toxicity studies
Loveinder Bhardwaj
 
Reproductive toxicology
Reproductive toxicologyReproductive toxicology
Reproductive toxicology
Aanchal46
 
Screening of anti-fertility agents.powerpointt
Screening of anti-fertility agents.powerpointtScreening of anti-fertility agents.powerpointt
Screening of anti-fertility agents.powerpointt
sujitha12341
 
BHAWANA SHARMA ppt ptsm 1.pptx
BHAWANA SHARMA ppt ptsm 1.pptxBHAWANA SHARMA ppt ptsm 1.pptx
BHAWANA SHARMA ppt ptsm 1.pptx
BhawanaSharma701242
 
Toxicology of genetically modified sheep meat
Toxicology of genetically modified sheep meatToxicology of genetically modified sheep meat
Toxicology of genetically modified sheep meat
Asma Bano
 
Experimental evaluation of antifertility agents
Experimental evaluation of antifertility agentsExperimental evaluation of antifertility agents
Experimental evaluation of antifertility agents
Akanksha William
 
Preclinical screening of antifertility agents. kahkesha
Preclinical screening of antifertility agents. kahkeshaPreclinical screening of antifertility agents. kahkesha
Preclinical screening of antifertility agents. kahkesha
kahkesha samshad
 
Screening model of antidiarrheal activity Presented by ABDUL HAMEED
Screening model of antidiarrheal activity Presented by ABDUL HAMEEDScreening model of antidiarrheal activity Presented by ABDUL HAMEED
Screening model of antidiarrheal activity Presented by ABDUL HAMEED
Abdul Hameed
 
Vet 2300 exotics and lab animal
Vet 2300 exotics and lab animalVet 2300 exotics and lab animal
Vet 2300 exotics and lab animal
stanbridge
 
Screening of ANTIFERTILITY AGENTS and APHRODISIACS
Screening of ANTIFERTILITY AGENTS and APHRODISIACSScreening of ANTIFERTILITY AGENTS and APHRODISIACS
Screening of ANTIFERTILITY AGENTS and APHRODISIACS
HimaniTailor
 
Pharmacological screening2 &amp; tox. studies
Pharmacological screening2 &amp; tox. studiesPharmacological screening2 &amp; tox. studies
Pharmacological screening2 &amp; tox. studies
Noor Alam
 
Antifertility screening
Antifertility screening Antifertility screening
Antifertility screening
Prerna Singh
 
F0351033038
F0351033038F0351033038
F0351033038
inventionjournals
 
Animal feeding trial on formulated rat diet
Animal feeding trial on formulated rat dietAnimal feeding trial on formulated rat diet
Animal feeding trial on formulated rat diet
Alexander Decker
 
Reproductive Toxicity studies TG 421.pptx
Reproductive Toxicity studies TG 421.pptxReproductive Toxicity studies TG 421.pptx
Reproductive Toxicity studies TG 421.pptx
RahulTipare
 
screening of anti-fertility agent
screening of anti-fertility agentscreening of anti-fertility agent
screening of anti-fertility agent
Jaineel Dharod
 
SAFETY PHARMACOLOGY STUDIES final .pptx
SAFETY PHARMACOLOGY STUDIES final .pptxSAFETY PHARMACOLOGY STUDIES final .pptx
SAFETY PHARMACOLOGY STUDIES final .pptx
RushikeshTidake
 
Teratogenicity.pptx
Teratogenicity.pptxTeratogenicity.pptx
Teratogenicity.pptx
ashharnomani
 
Scientific research of esulin in bi usm research and development esulix aifa ...
Scientific research of esulin in bi usm research and development esulix aifa ...Scientific research of esulin in bi usm research and development esulix aifa ...
Scientific research of esulin in bi usm research and development esulix aifa ...
Mohammad Suhaili Kasmat
 
Intermittent fasting improves the growth hormone secretion
Intermittent fasting improves the growth hormone secretionIntermittent fasting improves the growth hormone secretion
Intermittent fasting improves the growth hormone secretion
reabetsoe mogotsi
 

Similar to SUB ACUTE ORAL TOXICITY (20)

Reproductive toxicity studies
Reproductive toxicity studiesReproductive toxicity studies
Reproductive toxicity studies
 
Reproductive toxicology
Reproductive toxicologyReproductive toxicology
Reproductive toxicology
 
Screening of anti-fertility agents.powerpointt
Screening of anti-fertility agents.powerpointtScreening of anti-fertility agents.powerpointt
Screening of anti-fertility agents.powerpointt
 
BHAWANA SHARMA ppt ptsm 1.pptx
BHAWANA SHARMA ppt ptsm 1.pptxBHAWANA SHARMA ppt ptsm 1.pptx
BHAWANA SHARMA ppt ptsm 1.pptx
 
Toxicology of genetically modified sheep meat
Toxicology of genetically modified sheep meatToxicology of genetically modified sheep meat
Toxicology of genetically modified sheep meat
 
Experimental evaluation of antifertility agents
Experimental evaluation of antifertility agentsExperimental evaluation of antifertility agents
Experimental evaluation of antifertility agents
 
Preclinical screening of antifertility agents. kahkesha
Preclinical screening of antifertility agents. kahkeshaPreclinical screening of antifertility agents. kahkesha
Preclinical screening of antifertility agents. kahkesha
 
Screening model of antidiarrheal activity Presented by ABDUL HAMEED
Screening model of antidiarrheal activity Presented by ABDUL HAMEEDScreening model of antidiarrheal activity Presented by ABDUL HAMEED
Screening model of antidiarrheal activity Presented by ABDUL HAMEED
 
Vet 2300 exotics and lab animal
Vet 2300 exotics and lab animalVet 2300 exotics and lab animal
Vet 2300 exotics and lab animal
 
Screening of ANTIFERTILITY AGENTS and APHRODISIACS
Screening of ANTIFERTILITY AGENTS and APHRODISIACSScreening of ANTIFERTILITY AGENTS and APHRODISIACS
Screening of ANTIFERTILITY AGENTS and APHRODISIACS
 
Pharmacological screening2 &amp; tox. studies
Pharmacological screening2 &amp; tox. studiesPharmacological screening2 &amp; tox. studies
Pharmacological screening2 &amp; tox. studies
 
Antifertility screening
Antifertility screening Antifertility screening
Antifertility screening
 
F0351033038
F0351033038F0351033038
F0351033038
 
Animal feeding trial on formulated rat diet
Animal feeding trial on formulated rat dietAnimal feeding trial on formulated rat diet
Animal feeding trial on formulated rat diet
 
Reproductive Toxicity studies TG 421.pptx
Reproductive Toxicity studies TG 421.pptxReproductive Toxicity studies TG 421.pptx
Reproductive Toxicity studies TG 421.pptx
 
screening of anti-fertility agent
screening of anti-fertility agentscreening of anti-fertility agent
screening of anti-fertility agent
 
SAFETY PHARMACOLOGY STUDIES final .pptx
SAFETY PHARMACOLOGY STUDIES final .pptxSAFETY PHARMACOLOGY STUDIES final .pptx
SAFETY PHARMACOLOGY STUDIES final .pptx
 
Teratogenicity.pptx
Teratogenicity.pptxTeratogenicity.pptx
Teratogenicity.pptx
 
Scientific research of esulin in bi usm research and development esulix aifa ...
Scientific research of esulin in bi usm research and development esulix aifa ...Scientific research of esulin in bi usm research and development esulix aifa ...
Scientific research of esulin in bi usm research and development esulix aifa ...
 
Intermittent fasting improves the growth hormone secretion
Intermittent fasting improves the growth hormone secretionIntermittent fasting improves the growth hormone secretion
Intermittent fasting improves the growth hormone secretion
 

More from Arghya Chowdhury

Ptsd by arghya
Ptsd by arghyaPtsd by arghya
Ptsd by arghya
Arghya Chowdhury
 
PIED
PIEDPIED
Mono clonal Antibody
Mono clonal AntibodyMono clonal Antibody
Mono clonal Antibody
Arghya Chowdhury
 
Patient counceling arghya
Patient counceling arghyaPatient counceling arghya
Patient counceling arghya
Arghya Chowdhury
 
Alznovelarghyafinal
AlznovelarghyafinalAlznovelarghyafinal
Alznovelarghyafinal
Arghya Chowdhury
 
Smartphone on sleep
Smartphone on sleepSmartphone on sleep
Smartphone on sleep
Arghya Chowdhury
 
RT PCR
RT PCRRT PCR
Project amr by Arghya & Arnab
Project amr by Arghya & ArnabProject amr by Arghya & Arnab
Project amr by Arghya & Arnab
Arghya Chowdhury
 
Glutamatergic system by Arghya
Glutamatergic system by ArghyaGlutamatergic system by Arghya
Glutamatergic system by Arghya
Arghya Chowdhury
 

More from Arghya Chowdhury (9)

Ptsd by arghya
Ptsd by arghyaPtsd by arghya
Ptsd by arghya
 
PIED
PIEDPIED
PIED
 
Mono clonal Antibody
Mono clonal AntibodyMono clonal Antibody
Mono clonal Antibody
 
Patient counceling arghya
Patient counceling arghyaPatient counceling arghya
Patient counceling arghya
 
Alznovelarghyafinal
AlznovelarghyafinalAlznovelarghyafinal
Alznovelarghyafinal
 
Smartphone on sleep
Smartphone on sleepSmartphone on sleep
Smartphone on sleep
 
RT PCR
RT PCRRT PCR
RT PCR
 
Project amr by Arghya & Arnab
Project amr by Arghya & ArnabProject amr by Arghya & Arnab
Project amr by Arghya & Arnab
 
Glutamatergic system by Arghya
Glutamatergic system by ArghyaGlutamatergic system by Arghya
Glutamatergic system by Arghya
 

Recently uploaded

TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
DR SETH JOTHAM
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 

Recently uploaded (20)

TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 

SUB ACUTE ORAL TOXICITY

  • 1. Sub-acute oral toxicity study Prepared by, Arghya Chowdhury Roll No.:18162027 M.Pharm 2nd Semester Department of Pharmaceutical Engineering and Technology IIT(BHU), Varanasi
  • 2. Ethynyl estradiol • ANDA : 207081 on 05/17/2017 from AUROBINDO PHARMA LTD • CAS No. : 57-63-6 • An agonist of the estrogen receptors. • Used as contraception in combined oral contraceptives (COC) • Bioavailability : 38–48% • Protein binding : 97–98% (to albumin) • Elimination half-life : 7–36 hours • Excretion : Feces: 62% and Urine: 38% 2
  • 3. Evaluate the safety of ethynyl estradiol • The experimental protocol was approved by the IAEC (Institutional Animal Ethical Committee). • Care of the experimental animals taken according to the CPCSEA guidelines. • Sub-acute toxicity study was carried out in rats by using OECD 407 guidelines. 3
  • 4. Repeated Dose 28-Day Oral Toxicity Study • The test substance is orally administered daily in graduated doses to several groups, one dose level per group for a period of 28 days. • During this period the animals are observed closely, each day for signs of toxicity. • Endpoints : clinical observations, blood analysis, whole body gross necropsy, and micros- copic examination of all organs and tissues (histopathology). • Significance : the characterization of the test substance toxicity, for an indication of the dose response relationship and the determination of the No-Observed Adverse Effect Level (NOAEL). 4
  • 5. Animal handling and care • Temperature : 22°C (± 3°C). • Relative humidity : at least 55±5% with 12-h light/dark cycle (0600–1800 hours). • Animals: SD rats aged 6 weeks(130 gms-200 gms) of both sexes. • Access to food and water were maintained under standard laboratory conditions. • Housed individually in stainless steel, wire-mesh cages during the study. 5
  • 6. Study design • Grouping : Both sexes of rats (130-200g) were divided into four groups with 10 animals (5 males plus 5 females in each). • Dosing :  Group I (control)-olive oil solution (5 ml/kg)  Group II – 10 μg/kg EE  Group III – 50 μg/kg EE  Group IV – 200 μg/kg EE • Dosing frequency : Daily from 7 weeks of age for at least 28 days. 6
  • 7. Parameters • Euthanasia : exsanguination under ether anesthesia. • Blood samples collection : from the abdominal aorta. • Parameters considered : General observations Body weight and food consumption Hematology, Histopathological findings Spermatology, Estrous cycling 7
  • 8. General observations 8 • Autonomic activity (e.g. lacrimation, pupil size, respiratory pattern), • Changes in gait, posture, • Presence of clonic or tonic movements. • Sensory reactivity to stimuli of different types (e.g. auditory, visual), • Assessment of grip strength, • Motor activity assessment.
  • 9. Body weight and food consumption 9 • Individual body weight was recorded ; twice weekly immediately before necropsy. • Food consumption was measured weekly.
  • 10. Hematology, Histopathological findings 10 • Hematology examination : RBC count, WBC count, hemoglobin concentration, hematocrit value , platelet count, reticulocyte count, prothrombin time and differentiation of leukocytes. • Histopathological examination : organs were fixed in 10% neutral buffered formalin and examined: prostates(ventral prostate and dorsolateral prostate), seminal vesicles, ovaries, uterus, vagina, mammary gland, brain, thyroids, adrenals, liver, spleen, kidneys, heart, lungs, pancreas, thymus, parathyroids and pituitary glands. • The epididymes and testes were fixed in Bouin’s solution and examined.
  • 11. Spermatology, Estrous cycling • Spermatology : Sperm motility (100 spermatozoa in Ham’s F10 tissue culture medium at 37°C). Viability (decrease in motility during 5 min). • Estrous cycling : determined daily by vaginal smears stained with Gimsa from day 15 to the day 21. 1111
  • 12. Results • General observations : no abnormalities in rats given EE. • Food consumption was reduced in both males and females ; body weight gain significantly depressed only in the males of the 200 µg/kg group. • RBC counts decreased in females of 50 and 200 µg/kg groups ; haemoglobin concentration and haematocrit values decreased in males of 200 µg/kg group. • Abnormal estrous cycling was observed in female rats of the 50 and 200 µg/kg groups. • Adrenal cortical hyperplasia was detected in males ; Splenic hemosiderosis were detected in females of 200 µg/kg group. 12
  • 13. Analysis • Data obtained was analyzed by using one way ANOVA followed by Dunnett’s test and p<0.05 was considered as statistically significant. • Ethynyl estradiol taken orally exerts following toxic effects; Anemia, Breast tenderness, Atrophy of the prostates, Weight change. 1313
  • 14. References • Arch Toxicol (2002) 76: 65–74 • McLachlan JA, Korach KS (1995) Estrogens in the environment: global health implications. Environ Health Perspect 103: 3–4 14